Dierikon (ots) - In Wallisellen gibt es die erste Schweizer Thermomix-Showküche. Am Tag der offenen Tür ...
Vodafone UK and Medify Solutions Limited Deliver First Joint Sales Success
Stafford, England (ots/PRNewswire) - Medify Solutions and Vodafone UK are delighted to announce the first sales success of the Vodafone UK/Medify Solutions partnership.
This news comes within days of the MedifyRemote(TM) Vodafone Certified application status announcement and is the first success in delivering MedifyRemote(TM) to the Vodafone UK 155,000 strong NHS customer base.
The joint sales strategy has already booked two further joint sales meetings for January.
To deliver this result within days of the Vodafone announcement can only be viewed as a strong indication of the strength of the partnership and its ability to deliver immediate sales and revenue to both partners.
Nik Ellwood, Head of Sales and Marketing for Medify Solutions commented "This announcement is proof positive of the effectiveness of the Vodafone UK/Medify Solutions partnership. This early success comes on a wave of positive news from the Company and its ability to deliver."
Vodafone UK have also confirmed that MedifyRemote(TM) will be listed as a Certified application at www.vodafone.co.uk at the first opportunity within their website update schedule, estimated to be within four weeks further increasing the profile of the application within the Vodafone portfolio.
This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words "estimate," "project," "intends," "expects," " believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbour" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of Medify Solutions Limited, see "Risk Factors" in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
For further information: visit www.medifysolutions.com
(Pink Sheets - MDFY)
ots Originaltext: Medify Solutions Ltd.
Im Internet recherchierbar: http://www.presseportal.ch